close
close

Analyst Ratings Table: 9 Rating for Hims & Hers Health – Hims & Hers Health (NYSE:HIMS)

Analyst Ratings Table: 9 Rating for Hims & Hers Health – Hims & Hers Health (NYSE:HIMS)

Over the last three months, 9 analysts have shared their views on Hims & Hers Health HIMSVarious opinions have been expressed, ranging from a bull market to a bear market.

The chart below, which summarizes their latest assessments, shows the changing sentiments over the last 30 days and compares them to the previous months.

Bull A little bit of bull Indifferent A Little Bear Bear
Total Points 3 0 6 0 0
Last 30D 0 0 one 0 0
1M Ago one 0 one 0 0
2M Ago 2 0 one 0 0
3M First 0 0 3 0 0

Analysts have recently evaluated Hims & Hers Health and provided 12-month price targets. The average target is $19.67, accompanied by a high estimate of $26.00 and a low estimate of $13.00. This uptrend is evident, with the current average reflecting a 20.23% increase from the previous average price target of $16.36.

Analyzing Analyst Ratings: A Detailed Look

A comprehensive look at how financial experts perceive Hims & Hers Health is derived from recent analyst actions. Below is a detailed summary of key analysts, their recent evaluations, and adjustments to their ratings and price targets.

Analyst Analyst Firm Action Taken Evaluation Current Price Target Previous Price Target
Korinne Wolfmeyer Piper Sandler Increases Natural $18.00 $16.00
Glen Santangelo jeffery Increases To hold $23.00 $14.00
Michael Cherny B of A Securities Increases To buy $26.00 $22.00
Michael Cherny B of A Securities Increases To buy $22.00 $17.25
Maria Ripps Canaccord’s Sincerity Increases To buy $24.00 $20.00
Daniel Grosslight Citi Group Increases Natural $20.00 $16.00
George Hill German bank Increases To hold $16.00 $14.00
Korinne Wolfmeyer Piper Sandler Increases Natural $13.00 $11.00
Glen Santangelo jeffery It lowers To hold $15.00 $17.00

Basic knowledge:

  • Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Their stance of ‘Maintain,’ ‘Upgrade,’ or ‘Downgrade’ reflects their response to recent developments regarding Hims & Hers Health. This information provides a snapshot of how analysts perceive the company’s current health.
  • Evaluation: Analysts come up with qualitative ratings for stocks, ranging from ‘Outperform’ to ‘Underperform.’ These ratings provide insight into expectations regarding Hims & Hers Health’s relative performance compared to the broader market.
  • Price Targets: Analysts who understand forecasts offer estimates for the future value of Hims & Hers Health. Examining current and previous targets provides insight into analysts’ changing expectations.

Understanding these analyst ratings along with key financial indicators can offer valuable insights into Hims & Hers Health’s market position. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Hims & Hers Health analyst ratings.

Exploring His and Hers Health: A Closer Look

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals and provides them with access to high-quality medical care for a wide range of conditions including mental health, sexual health, dermatology, primary care and more.

Understanding the Numbers: Hims & Hers Health’s Finances

Market capitalization: The market value of the company, which has a smaller size compared to the industry averages, presents its own challenges.

Income increase: Hims & Hers Health’s outstanding 3-month performance speaks for itself. The company has achieved an impressive revenue growth rate as of March 31, 2024. 45.81%This represents a significant increase in the company’s top-line earnings. Compared to its industry peers, the company stands out with a higher than average growth rate among its peers in the Healthcare sector.

Net Profit Margin: Hims & Hers Health’s financial strength is reflected in its outstanding net profit margin, which exceeds industry averages. With its outstanding net profit margin, 4.0%, The company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Hims & Hers Health’s financial strength is reflected in its outstanding ROE, which exceeds industry averages. With outstanding ROE 3.23%, The company stands out with its effective use of equity capital and strong financial health.

Return on Assets (ROA): Hims & Hers Health’s ROA exceeds industry standards, highlighting the company’s outstanding financial performance. An impressive 2.5% ROA ensures that the company is using its assets effectively for the best return.

Debt management: Hims & Hers Health’s debt-to-equity ratio is below industry norms, indicating a solid financial structure at 100%. 0.03.

What Are Analyst Ratings?

Benzinga tracks 150 analyst firms and reports on stock expectations. Analysts typically arrive at their conclusions by estimating how much money a company will make in the future, typically in the next five years, and how risky or predictable that company’s revenue streams are.

Analysts attend company conference calls and meetings, research company financials, and communicate with insiders to issue their ratings on stocks. Analysts typically rate each stock quarterly or when the company makes a significant update.

Some analysts will also offer estimates for metrics such as growth estimates, earnings, and revenue to provide further guidance on stocks. Investors using analyst ratings should remember that this particular advice comes from humans and can be prone to error.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.